SeaStar Medical Holding Corp: INTRACOASTAL CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
IntraCoastal Capital LLC amended its Schedule 13G filing for SeaStar Medical Holding Corp, disclosing its updated passive stake in the medical device company via SEC accession 0001213900-26-118160. The filing, submitted under the 13G framework used by investors holding below the 5% active-ownership threshold, signals a routine position update rather than a strategic shift. SeaStar Medical, which develops therapies for organ failure, remains a micro-cap name where institutional position changes can carry outsized signaling weight. Specific share counts and percentage figures were not detailed in the headline disclosure. Investors will watch for the full filing text to confirm whether IntraCoastal's stake increased or decreased, and for any subsequent 13D filing should its position cross the active-investor threshold.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
SeaStar Medical Holding Corp, Intracoastal Capital, LLC